(Q53122149)

11 May 2018

title

Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia. (English)

1 reference

11 May 2018

1 reference

Philadelphia chromosome

1 reference

object named as

Philadelphia chromosome

2 August 2024

8

1 reference

11 May 2018

Ishikazu Mizuno

17

object named as

Ishikazu Mizuno

1 reference

11 May 2018

author name string

Shinichi Kako

1

1 reference

11 May 2018

Heiwa Kanamori

2

1 reference

11 May 2018

Naoki Kobayashi

3

1 reference

11 May 2018

Akio Shigematsu

4

1 reference

11 May 2018

Yasuhito Nannya

5

1 reference

11 May 2018

Mika Nakamae

6

1 reference

11 May 2018

Kazuyuki Shigeno

7

1 reference

11 May 2018

Masahiro Takeuchi

9

1 reference

11 May 2018

Motohiro Tsuzuki

10

1 reference

11 May 2018

Kensuke Usuki

11

1 reference

11 May 2018

Kazuo Hatanaka

12

1 reference

11 May 2018

Kazuei Ogawa

13

1 reference

11 May 2018

Kinuko Mitani

14

1 reference

11 May 2018

Yuichiro Nawa

15

1 reference

11 May 2018

Yoshihiro Hatta

16

1 reference

11 May 2018

Yoshinobu Kanda

18

1 reference

11 May 2018

language of work or name

English

0 references

publication date

1 February 2013

1 reference

11 May 2018

British Journal of Haematology

published in

1 reference

11 May 2018

volume

161

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

95-103

1 reference

11 May 2018

Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia

cites work

1 reference

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

21 January 2018

1 reference

Salvage therapy for refractory or relapsed acute lymphocytic leukemia

21 January 2018

1 reference

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.

21 January 2018

1 reference

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

21 January 2018

1 reference

Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia

21 January 2018

1 reference

The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia.

21 January 2018

1 reference

Evolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults

21 January 2018

1 reference

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

21 January 2018

1 reference

Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

21 January 2018

1 reference

FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia

21 January 2018

1 reference

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

21 January 2018

1 reference

A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12225

1 reference

11 May 2018

1 reference

11 May 2018